News overview

Peter Hermans appointed Professor in Infection and Immunology Trials

Peter Hermans has been appointed Professor in Infection and Immunology Trials at Utrecht University/UMC Utrecht.

DENSE research wins Science and Innovation Award 2021

Breast cancer in women with dense mammary gland tissue is better detectable with an MRI

Inaugural lecture by Seye Abimbola about health inequality

Why are people in certain countries healthier than others, and is there a correlation with how the health care system is organized? As holder of the Prince Claus Chair, Seye Abimbola, Professor of Global Health Research, researches what is needed to improve health equity in the world. On June 10 he held his inaugural lecture “Justice in Global Health Research” in the presence of Queen Máxima, patroness of this Chair.

Carla van Gils new director KWF

Prof. Dr. Carla van Gils will be part of the management of KWF Kankerbestrijding from 1 June. She will combine this function with her research work at the Julius Centrum UMC Utrecht.

Initial results of BCM-PRIME study: Tuberculosis vaccine does not protect vulnerable elderly people against COVID-19

The BCG vaccine does not offer vulnerable elderly people protection against the symptoms of COVID-19. These are the initial results of the BCG-PRIME study among 6,132 vulnerable patients aged 60 and over.

Plasma antibody does not help the sickest COVID-19 patient

Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, therapeutic anticoagulation drugs did not improve outcomes. Enrollment continues for moderately ill hospitalized COVID-19 patients in the trials.

When does home monitoring work for patients with heart failure?

The UMC Utrecht is launching a large-scale study into the effectiveness of telehealth coaching in patients with heart failure.

Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrollment of Critically Ill COVID-19 Patients

Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients.

UMC Utrecht starts clinical trial with COVID-19 vaccine

UMC Utrecht will start a study with the COVID-19 candidate vaccine from CureVac on 28 December. A total of approximately 2,000 volunteers in the Netherlands will be recruited to participate in this study.